Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SPY
7. SMTC
8. NCNO
9. BOX
10. CRM

Go back to Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases
(NASDAQ: CRDL) Delayed: 2.14 +0.14 (7.00%)
Previous Close $2.00    52 Week High $ 
Open $2.03    52 Week Low $ 
Day High $2.28    P/E N/A 
Day Low $2.01    EPS $ 
Volume 4,531,893